Since the 2018 Farm Bill legalized hemp, there are now two distinct commercial industries: pharmaceuticals / wellness and industrial. In the pharmaceutical and consumer wellness areas, there is an explosion of innovation and new products. In the industrial market, there is increasing interest in light of sustainability and carbon capture considerations.
Attendees will leave this panel with a deeper understanding of the current hemp and CBD legislation and proposed legislative solutions to current regulatory and legal challenges facing the hemp and hemp-derived cannabinoid industries. Panelists will do a deep dive into current legislative proposals, as well as approaches for the 2023 Farm Bill.
As hemp policy continues to evolve, ensure you are staying at the forefront of regulatory developments to provide your clients with the best counsel for the 2021 production season.
With a new Administration and Congress, changes in personnel at FDA and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50state?
The franchise business model offers hemp business owners the opportunity to grow their brand nationally while reducing their startup and operational costs. It offers prospective hemp franchisees the chance to own their own business while benefiting from an established brand and operational system. But a poorly created franchise system or an “accidental” franchise, can expose hemp businesses to the risk of regulatory investigation, litigation, and the loss of key IP such as trademarks and trade secrets. Conflicting state regulations and the lack of significant federal guidance makes franchising a hemp business even more complex.
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.